The US government has awarded Novavax, a company based in Gaithersburg, Maryland, $1.6 billion to help develop and make the vaccine, which is given as two shots, three weeks apart. It includes a protein from the coronavirus to prompt the immune system to make antibodies to fight infection.

from Times of India https://timesofindia.indiatimes.com/world/us/covid-19-early-vaccine-results-show-no-major-safety-issue/articleshow/77907325.cms